Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Change in Acquisitions & Divestments (2020)

TELA Bio (TELA) has 1 years of Change in Acquisitions & Divestments data on record, last reported at $5.3 million in Q2 2020.

  • For Q2 2020, Change in Acquisitions & Divestments changed N/A year-over-year to $5.3 million; the TTM value through Dec 2020 reached $9.3 million, changed N/A, while the annual FY2020 figure was $9.3 million, N/A changed from the prior year.
  • Change in Acquisitions & Divestments reached $5.3 million in Q2 2020 per TELA's latest filing, up from $4.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $5.3 million in Q2 2020 and bottomed at $4.0 million in Q1 2020.